LifeVantage Corporation
- Open
- 6.18
- Day high
- 6.39
- Day low
- 6.16
- Prev close
- 6.24
- Volume
- 57K
- Mkt cap
- $79M
- P/E (TTM)
- 13.6
- EPS (TTM)
- $0.46
- P/B
- 2.4
- P/S
- 0.4
- Yield
- 2.96%
- Per share
- $0.18
- ▼Insiders net selling -$79K over the last 3 months (1 open-market buy, 1 sale)
- 🏛Institutions accumulating (13F)
LifeVantage Corporation (LFVN) is a Consumer Defensive company listed on NASDAQ. The stock is down 53% over the past year. Over the trailing 3 months, insiders filed 1 open-market buy and 1 sale (SEC Form 4).
LifeVantage Corporation (LFVN) financials & analyst ratings
Fundamentals (TTM)
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
LFVN earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 6, 2026 | $0.16 | $0.12 | -25.0% | $44M | -8.5% |
| Feb 4, 2026 | $0.22 | $0.15 | -31.8% | $49M | -5.6% |
| Nov 4, 2025 | $0.17 | $0.18 | +5.9% | $58M | +7.4% |
| Sep 4, 2025 | $0.17 | $0.17 | +0.0% | $55M | -4.9% |
| Feb 5, 2025 | $0.13 | $0.22 | +69.2% | $68M | +0.5% |
| May 2, 2024 | $0.16 | $0.21 | +31.2% | $48M | -5.3% |
| Jan 30, 2024 | $0.04 | $0.10 | +150.0% | $52M | -7.0% |
| Nov 9, 2023 | — | $0.13 | — | $51M | -76.6% |
| Aug 28, 2023 | $0.20 | $0.17 | -15.0% | $54M | +6.4% |
| May 4, 2023 | $0.15 | $0.08 | -46.7% | $54M | +5.5% |
| Feb 2, 2023 | $0.05 | $-0.07 | -240.0% | $54M | +4.9% |
| Nov 2, 2022 | $0.15 | $0.06 | -60.0% | $52M | +3.0% |
LFVN insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 17, 2026 | Lewis Darwindirector | Buy | 705 | $8.60 |
| Jun 5, 2026 | BEINDORFF MICHAEL Adirector | Sell | 10,000 | $8.55 |
| Apr 3, 2026 | Cunningham Kristenofficer: Chief Sales Officer | Tax | 1,928 | $4.20 |
| Apr 3, 2026 | Neufeld Alissaofficer: General Counsel | Tax | 1,446 | $4.20 |
| Apr 3, 2026 | Fife Steven Rdirector, officer: President and CEO | Tax | 8,180 | $4.20 |
| Apr 3, 2026 | Aure Carlofficer: Chief Financial Officer | Tax | 1,527 | $4.20 |
| Mar 2, 2026 | Dayton Judddirector | Buy | 10,500 | $4.53 |
| Mar 2, 2026 | Dayton Judddirector | Buy | 18,097 | $4.63 |
| Mar 2, 2026 | Dayton Judddirector | Buy | 4,600 | $4.58 |
| Feb 11, 2026 | Lewis Darwindirector | Buy | 3,955 | $5.22 |
| Jan 5, 2026 | Aure Carlofficer: Chief Financial Officer | Tax | 1,527 | $6.16 |
| Jan 5, 2026 | Cunningham Kristenofficer: Chief Sales Officer | Tax | 1,926 | $6.16 |
| Jan 5, 2026 | Fife Steven Rdirector, officer: President and CEO | Tax | 9,169 | $6.16 |
| Jan 5, 2026 | Neufeld Alissaofficer: General Counsel | Tax | 1,445 | $6.16 |
| Dec 29, 2025 | Thompson Toddofficer: Chief Information Officer | Tax | 601 | $6.23 |
Source: LFVN SEC Form 4 filings, latest Jun 17, 2026. For informational purposes only — not investment advice.
See the full LFVN insider & 13F page →LifeVantage Corporation company profile
Overview
LifeVantage Corporation (NASDAQ:LFVN) is a Utah-based company founded in 2003 that develops and markets nutritional supplements and personal care products through a direct sales network marketing model. The company went public in 1994 and has evolved from its early focus on anti-aging research to become what it calls an "activation company," emphasizing products that restore and optimize natural bodily processes. LifeVantage operates primarily in the United States but has expanded internationally to markets including Japan, Australia, Mexico, and several European countries, selling through a network of independent distributors rather than traditional retail channels.
Business
LifeVantage operates in the nutritional supplements and personal care industry, specifically within the direct sales or multi-level marketing (MLM) sector. The company develops, manufactures, and distributes what it calls "nutrigenomic activators" - supplements designed to activate genes and cellular pathways that support health and wellness. The company's product portfolio spans several categories. Protandim represents their flagship line of scientifically validated dietary supplements, including the Nrf2 Synergizer which targets oxidative stress reduction. The recently launched MindBody GLP-1 System has become a primary growth driver, designed as a natural weight management solution that clinical studies show increases GLP-1 hormone levels by up to 200%. Other key products include LifeVantage Omega+ (omega fatty acids with vitamin D3), PhysIQ weight management products, and Axio energy drink mixes. The personal care segment operates under the TrueScience brand, offering anti-aging skincare products, hair care solutions, and bath and body products. TrueScience Liquid Collagen has emerged as a top performer, contributing approximately 23% of total revenue in recent quarters. Based on recent financial reports, the Americas region (primarily the United States) generates roughly 80-85% of total revenue, while the Asia-Pacific and Europe regions contribute the remaining 15-20%. The nutritional supplements segment dominates revenue generation, with personal care products representing a smaller but growing portion of the business.
Revenue model
LifeVantage operates on a direct sales business model, generating revenue primarily through product sales to end consumers via a network of independent distributors. The company does not sell through traditional retail channels but instead relies on distributors who purchase products at wholesale prices and resell them to customers or consume them personally. Distributors earn commissions on their sales and can also earn bonuses by recruiting and developing teams of other distributors. The company's revenue streams include direct product sales, with customers increasingly adopting subscription models that provide recurring revenue. Recent data shows approximately 85% of customers purchasing the new MindBody system opt for subscription delivery, compared to a historical average of 70% across all products. This subscription model provides more predictable cash flows and higher customer lifetime value. Several factors influence LifeVantage's profitability margins. Positive margin drivers include the high-margin nature of nutritional supplements (gross margins consistently above 80%), the recurring revenue from subscription customers, and the company's direct-to-consumer model that eliminates traditional retail markups. The company's focus on proprietary, scientifically-backed formulations also supports premium pricing. Margin pressures come from raw material cost inflation, particularly for specialized ingredients used in their formulations. International expansion costs, including regulatory compliance and market entry expenses, can temporarily depress margins. The direct sales model also requires significant investment in distributor support, training, and incentive programs. Competition from other supplement companies and changing consumer preferences toward different wellness trends could pressure pricing power. Additionally, regulatory changes in the supplement industry or MLM sector could impact both costs and revenue generation.
Competitive moat
LifeVantage's competitive moat appears relatively narrow, typical of companies in the nutritional supplements industry. The company's primary defensive characteristics include its proprietary formulations with clinical research backing, particularly for products like Protandim and the MindBody GLP-1 system. The clinical studies demonstrating measurable physiological effects provide some differentiation from generic supplement competitors. The direct sales network represents both a strength and vulnerability. While the established distributor base creates switching costs and provides market reach without traditional advertising expenses, this model faces ongoing regulatory scrutiny and social stigma associated with MLM structures. The network effect becomes stronger as successful distributors develop teams, but remains dependent on continuous recruitment and retention. Brand recognition within the wellness community and scientific credibility from published research provide modest protection, but the supplement industry remains highly fragmented with low barriers to entry. New entrants can relatively easily develop competing formulations, and larger pharmaceutical or consumer goods companies could enter with superior resources. The company faces significant competitive threats from established supplement brands, pharmaceutical companies developing over-the-counter wellness products, and the growing direct-to-consumer supplement market enabled by e-commerce platforms. The MLM model itself faces increasing competition from social media influencers and affiliate marketing programs that offer similar income opportunities with potentially better reputations. Overall, LifeVantage operates in a competitive landscape with limited sustainable competitive advantages.
Risks & safety
LifeVantage demonstrates a solid financial foundation with moderate safety margins, though growth-stage characteristics create some variability. • **Liquidity position**: Strong with $22.5 million cash and no debt, providing substantial operational flexibility • **Current ratio**: 1.66x indicates adequate short-term liquidity coverage • **Cash flow**: Positive operating cash flow of $2.2 million in Q3 2025, though historically volatile • **Debt burden**: Debt-free balance sheet eliminates solvency risk • **Valuation metrics**: - P/E ratio of 13.0x appears reasonable for growth expectations - EV/EBITDA of 8.7x suggests moderate valuation - Price-to-book of 5.3x reflects asset-light business model • **Other considerations**: MLM business model creates regulatory and reputational risks; revenue concentration in Americas region increases geographic risk; dependence on distributor network creates operational vulnerabilities during economic downturns.
Recent development
Over the past few years, LifeVantage has undergone a significant strategic transformation called LV360, repositioning itself as an "activation company" focused on products that restore natural bodily processes. The most significant recent development has been the launch of the MindBody GLP-1 System in October 2024, which has become the company's primary growth driver. Clinical studies demonstrated that this natural weight management system increases GLP-1 hormone levels by 140-200%, with participants losing an average of 9 pounds in 8 weeks while maintaining muscle mass. The company has modernized its compensation structure with the Evolve plan, designed to better attract and retain distributors across different engagement levels. This includes enhanced sharing bonuses, double bonuses for new consultants, and partnerships to offer health insurance benefits to distributors. The plan addresses previous gaps in the compensation structure and aims to appeal to both product sellers and business builders. International expansion has accelerated, with the MindBody system launching across multiple markets including Japan, Australia, New Zealand, Mexico, UK, Europe, and Thailand. The company expects to complete its global rollout by early summer 2025. Product innovation has focused on the TrueScience Liquid Collagen, which has become a top performer contributing approximately 23% of revenue, and the development of "activation stacks" that combine multiple products for targeted health benefits. Digital capabilities have been enhanced through improved mobile apps for distributors, better social media strategies, and increased focus on attracting social sellers and influencers to expand beyond the traditional MLM model. The company has also optimized its Rewards Circle loyalty program to improve customer retention and increase subscription adoption rates.
LFVN company profile · for informational purposes only — not investment advice.
Track LFVN with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free